Noninvasive Brain Stimulation for Pain Relief
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT04283643 |
Recruitment Status :
Recruiting
First Posted : February 25, 2020
Last Update Posted : February 25, 2020
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease | Intervention/treatment | Phase |
---|---|---|
Pain, Acute Pain, Chronic Pain, Experimental | Other: Transcranial Focused Ultrasound Other: Transcranial Magnetic Stimulation | Not Applicable |
The research team will be using non-invasive brain stimulation techniques, transcranial magnetic stimulation (TMS) and transcranial focused ultrasound (FUS) to investigate their uses for pain relief in humans: healthy human subjects, acute pain patients, and chronic pain patients. Magnetic Resonance Imaging (MRI) and electroencephalogram (EEG) recordings will be collected to achieve the following objectives:
Objective 1 aims to determine the effects of noninvasive brain stimulation on the pain-related brain activities during pain processing. We hypothesize that noninvasive brain stimulation approaches will increase or decrease cortical activity upon processing painful input.
Objective 2 aims to determine the effects of noninvasive brain stimulation on pain intensity and/or pain-related behavioral assessments. We hypothesize that noninvasive brain stimulation will influence pain-intensity and/or pain-related behavioral assessments.
Objective 3 aims to investigate the correlation between brain activity and pain relief after noninvasive brain stimulation. We hypothesize that noninvasive brain stimulation will suppress cortical activity in pain-related brain areas, reduce pain intensity, and/or improve pain-related behavioral assessments.
Study Type : | Interventional (Clinical Trial) |
Estimated Enrollment : | 149 participants |
Allocation: | Randomized |
Intervention Model: | Parallel Assignment |
Intervention Model Description: | Within subjects design of real and control stimulation, pain measures and behavioral assessments may be compared between healthy subjects and pain groups. |
Masking: | Single (Participant) |
Primary Purpose: | Basic Science |
Official Title: | Noninvasive Brain Stimulation for Pain Relief |
Actual Study Start Date : | April 1, 2019 |
Estimated Primary Completion Date : | April 1, 2021 |
Estimated Study Completion Date : | April 1, 2021 |
Arm | Intervention/treatment |
---|---|
Experimental: Healthy Human Subjects
Healthy human subjects will complete study procedures in the research lab at UVA. They will complete pain-related behavioral questionnaires and undergo experimental pain testing for temperature and laser stimuli for real and control conditions of brain stimulation.
|
Other: Transcranial Focused Ultrasound
Non-invasive brain stimulation technique Other: Transcranial Magnetic Stimulation Non-invasive brain stimulation technique |
Experimental: Acute Pain Patients
Acute Pain Patients will complete study procedures in the hospital or clinic at UVA. They will complete pain-related behavioral questionnaires and undergo experimental pain testing for temperature and laser stimuli for real and control conditions of brain stimulation, as well as rate their ongoing pain.
|
Other: Transcranial Focused Ultrasound
Non-invasive brain stimulation technique Other: Transcranial Magnetic Stimulation Non-invasive brain stimulation technique |
Experimental: Chronic Pain Patients
Chronic Pain Patients will complete study procedures in the hospital or clinic at UVA. They will complete pain-related behavioral questionnaires and undergo experimental pain testing for temperature and laser stimuli for real and control conditions of brain stimulation, as well as rate their ongoing pain.
|
Other: Transcranial Focused Ultrasound
Non-invasive brain stimulation technique Other: Transcranial Magnetic Stimulation Non-invasive brain stimulation technique |
- Numeric Pain Rating Scale [ Time Frame: immediately after brain stimulation (same day, approximately 5-10 minutes after baseline) as compared to baseline ]Participants will rate their pain (experimental, acute, chronic) on a 1-10 scale
- Numeric Pain Rating Scale [ Time Frame: immediately after experimental pain measure (up to 15 minutes after baseline) as compared to baseline ]Participants will rate their pain (experimental, acute, chronic) on a 1-10 scale

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 18 Years to 80 Years (Adult, Older Adult) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | Yes |
Inclusion Criteria:
- Healthy adults between 18 and 80 years of age.
- Chronic and Acute pain patients: must have an MRI (for ultrasound targeting)
Exclusion Criteria:
- Direct report to the study team member
- History of brain surgery
- History of seizure
- Pregnant
- Have alcohol consumption exceeding 50 drinks/month
- Have history of opioid abuse (all subjects), or any recent opioid use (healthy controls)
- Have implant like pacemaker and aneurysm clip
- Current of psychiatric disease such as anxiety or depression, which is not optimally treated
- Current infection
- Current wound on the skin of upper and lower extremities
- Chronic pain patients: current chronic pain is not optimal controlled by pain medications (i.e. Pain VAS >5)

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT04283643
United States, Virginia | |
University of Virginia | Recruiting |
Charlottesville, Virginia, United States, 22903 | |
Contact: Sarah Adams 434-243-4319 neuromodlab@hscmail.mcc.virginia.edu | |
Principal Investigator: Chang-Chia Liu, PhD |
Responsible Party: | University of Virginia |
ClinicalTrials.gov Identifier: | NCT04283643 |
Other Study ID Numbers: |
21311 |
First Posted: | February 25, 2020 Key Record Dates |
Last Update Posted: | February 25, 2020 |
Last Verified: | February 2020 |
Individual Participant Data (IPD) Sharing Statement: | |
Plan to Share IPD: | Undecided |
Studies a U.S. FDA-regulated Drug Product: | No |
Studies a U.S. FDA-regulated Device Product: | No |
Transcranial Magnetic Stimulation Focused Ultrasound Noninvasive Neuromodulation |
Acute Pain Chronic Pain Pain Neurologic Manifestations |